• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于F-氟贝他班和F-氟代甲磺酸美他莫尔PET的新的百分制方法,无需转换为匹兹堡化合物B。

A new Centiloid method for F-florbetaben and F-flutemetamol PET without conversion to PiB.

作者信息

Cho Soo Hyun, Choe Yeong Sim, Kim Hee Jin, Jang Hyemin, Kim Yeshin, Kim Si Eun, Kim Seung Joo, Kim Jun Pyo, Jung Young Hee, Kim Byeong C, Baker Suzanne L, Lockhart Samuel N, Na Duk L, Park Seongbeom, Seo Sang Won

机构信息

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Department of Neurology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.

出版信息

Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1938-1948. doi: 10.1007/s00259-019-04596-x. Epub 2019 Dec 13.

DOI:10.1007/s00259-019-04596-x
PMID:31834446
Abstract

PURPOSE

We developed a new method to directly calculate Centiloid (CL) units of F-florbetaben (FBB) and F-flutemetamol (FMM) without conversion to the PiB standardized uptake value ratio (SUVR).

METHODS

Paired FBB and FMM PET scans were obtained from 20 Alzheimer's disease-related cognitive impairment patients, 16 old controls, and 20 young controls. We investigated the correlations between the FBB and FMM CL units using the direct comparison of FBB-FMM CL (dcCL) method and the standard CL method and compare differences in FBB and FMM CL units between dcCL method and the standard method.

RESULTS

Following the conversion of FBB or FMM SUVRs into CL units, a direct relationship was formed between the FBB or FMM SUVRs and the CL units using dcCL method (FBB dcCL = 151.42 × FBB dcSUVR - 142.24 and FMM dcCL = 148.52 × FMM dcSUVR - 137.09). The FBB and FMM CL units were highly correlated in both our method (R = 0.97, FMM dcCL = 0.97 × FBB dcCL + 1.64) and the standard method (R = 0.97, FMM CLstandard = 0.79 × FBB CLstandard + 1.36). However, the CL variations between FBB and FMM were smaller when calculated by dcCL method (6.15) than when calculated by the previous method (10.22; P = 0.01).

CONCLUSIONS

Our findings suggest that our direct comparison of FBB-FMM method, rather than the standard method, is a reasonable way to convert FBB or FMM SUVRs into CL units, at least in environments where FBB or FMM ligands are used frequently.

摘要

目的

我们开发了一种新方法,可直接计算F-氟贝他班(FBB)和F-氟代甲磺酸美他莫(FMM)的百分位数(CL)单位,而无需转换为匹兹堡化合物B标准化摄取值比率(SUVR)。

方法

对20例阿尔茨海默病相关认知障碍患者、16例老年对照者和20例年轻对照者进行了FBB和FMM的PET配对扫描。我们使用FBB-FMM CL(dcCL)直接比较法和标准CL法研究了FBB和FMM CL单位之间的相关性,并比较了dcCL法和标准法之间FBB和FMM CL单位的差异。

结果

将FBB或FMM SUVR转换为CL单位后,使用dcCL法在FBB或FMM SUVR与CL单位之间形成了直接关系(FBB dcCL = 151.42 × FBB dcSUVR - 142.24和FMM dcCL = 148.52 × FMM dcSUVR - 137.09)。在我们的方法(R = 0.97,FMM dcCL = 0.97 × FBB dcCL + 1.64)和标准方法(R = 0.97,FMM CLstandard = 0.79 × FBB CLstandard + 1.36)中,FBB和FMM CL单位均高度相关。然而,用dcCL法计算时FBB和FMM之间的CL变化(6.15)比用先前方法计算时(10.22;P = 0.01)更小。

结论

我们的研究结果表明,我们的FBB-FMM直接比较法,而非标准方法,是将FBB或FMM SUVR转换为CL单位的合理方法,至少在频繁使用FBB或FMM配体的环境中如此。

相似文献

1
A new Centiloid method for F-florbetaben and F-flutemetamol PET without conversion to PiB.一种用于F-氟贝他班和F-氟代甲磺酸美他莫尔PET的新的百分制方法,无需转换为匹兹堡化合物B。
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1938-1948. doi: 10.1007/s00259-019-04596-x. Epub 2019 Dec 13.
2
Appropriate reference region selection of F-florbetaben and F-flutemetamol beta-amyloid PET expressed in Centiloid.以百分位值表示的 F-氟比他滨和 F-氟美特胺β-淀粉样蛋白 PET 的适当参考区选择。
Sci Rep. 2020 Sep 11;10(1):14950. doi: 10.1038/s41598-020-70978-z.
3
F-Florbetaben PET beta-amyloid binding expressed in Centiloids.F-Florbetaben PET 以百分位值表示的β-淀粉样蛋白结合。
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2053-2059. doi: 10.1007/s00259-017-3749-6. Epub 2017 Jun 22.
4
Head-to-Head Comparison of 18F-Florbetaben and 18F-Flutemetamol in the Cortical and Striatal Regions.18F-氟比他滨与 18F-氟脱氧葡萄糖在皮质和纹状体区域的头对头比较。
J Alzheimers Dis. 2020;76(1):281-290. doi: 10.3233/JAD-200079.
5
Concordance in detecting amyloid positivity between F-florbetaben and F-flutemetamol amyloid PET using quantitative and qualitative assessments.使用定量和定性评估方法,氟[18F]氟比他滨和氟[18F]氟脱氧葡萄糖 PET 检测淀粉样蛋白阳性的一致性。
Sci Rep. 2020 Nov 11;10(1):19576. doi: 10.1038/s41598-020-76102-5.
6
Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET.基于 CT 的区域性改良 Centiloid 方法在淀粉样 PET 中的开发和临床验证。
Alzheimers Res Ther. 2022 Oct 20;14(1):157. doi: 10.1186/s13195-022-01099-0.
7
Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach.以多中心 PET 研究方法验证 centiloids 中淀粉样 PET 阳性阈值。
Alzheimers Res Ther. 2021 May 10;13(1):99. doi: 10.1186/s13195-021-00836-1.
8
[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease.[18F]氟替美仑淀粉样蛋白-β PET 成像与 [11C]PIB 在阿尔茨海默病谱中的比较。
Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):290-300. doi: 10.1007/s00259-013-2564-y. Epub 2013 Oct 2.
9
Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease.11C-PiB 和 18F-氟比他滨在衰老和阿尔茨海默病中的 Aβ 成像比较。
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):983-9. doi: 10.1007/s00259-012-2088-x. Epub 2012 Mar 8.
10
Harmonisation of PET imaging features with different amyloid ligands using machine learning-based classifier.使用基于机器学习的分类器对不同淀粉样蛋白配体的 PET 成像特征进行协调。
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):321-330. doi: 10.1007/s00259-021-05499-6. Epub 2021 Jul 30.

引用本文的文献

1
Mapping Alzheimer's disease pathology using free water through integrated analysis of plasma biomarkers, microstructural DTI metrics, and macrostructural MRI measures.通过对血浆生物标志物、微观结构扩散张量成像(DTI)指标和宏观结构磁共振成像(MRI)测量值进行综合分析,利用自由水绘制阿尔茨海默病病理图谱。
Sci Rep. 2025 Aug 21;15(1):30702. doi: 10.1038/s41598-025-14200-y.
2
Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups.血浆磷酸化tau 217和淀粉样蛋白β 42/40用于亚组中的淀粉样蛋白风险评估
Alzheimers Res Ther. 2025 Aug 7;17(1):184. doi: 10.1186/s13195-025-01826-3.
3
Integrating visual assessments and quantification methods for tau PET staging.
整合用于tau蛋白正电子发射断层显像(PET)分期的视觉评估和定量方法。
Alzheimers Dement. 2025 Jun;21(6):e70352. doi: 10.1002/alz.70352.
4
Establishing Regional Aβ Cutoffs and Exploring Subgroup Prevalence Across Cognitive Stages Using BeauBrain Amylo.利用BeauBrain淀粉样蛋白确定区域Aβ临界值并探索认知阶段亚组患病率。
Dement Neurocogn Disord. 2025 Apr;24(2):135-146. doi: 10.12779/dnd.2025.24.2.135. Epub 2025 Apr 9.
5
Cross-ancestry genome-wide association study identifies implications of SORL1 in cerebral beta-amyloid deposition.跨血统全基因组关联研究确定了SORL1在脑β-淀粉样蛋白沉积中的作用。
Nat Commun. 2025 Apr 2;16(1):3150. doi: 10.1038/s41467-025-57751-4.
6
Distinct Characteristics of Suspected Non-Alzheimer Pathophysiology in Relation to Cognitive Status and Cerebrovascular Burden.与认知状态和脑血管负担相关的疑似非阿尔茨海默病病理生理学的独特特征。
Clin Nucl Med. 2025 May 1;50(5):368-380. doi: 10.1097/RLU.0000000000005793. Epub 2025 Mar 3.
7
Comparison of accumulation rates of beta-amyloid tracers and their relationship with cognitive changes.β-淀粉样蛋白示踪剂的积累率比较及其与认知变化的关系。
Sci Rep. 2025 Feb 27;15(1):7072. doi: 10.1038/s41598-025-90642-8.
8
Association between focal amyloid deposition and cognitive impairment in individuals below the amyloid threshold.淀粉样蛋白阈值以下个体的局灶性淀粉样蛋白沉积与认知障碍之间的关联。
Front Aging Neurosci. 2024 Oct 30;16:1452081. doi: 10.3389/fnagi.2024.1452081. eCollection 2024.
9
Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors.血浆阿尔茨海默病生物标志物的变异性:不依赖淀粉样蛋白和依赖淀粉样蛋白的因素。
Alzheimers Dement. 2025 Jan;21(1):e14368. doi: 10.1002/alz.14368. Epub 2024 Nov 13.
10
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study.在 Centiloids 中探究可靠的淀粉样蛋白沉积:来自 AMYPAD 预后和自然史研究的结果。
Alzheimers Dement. 2024 May;20(5):3429-3441. doi: 10.1002/alz.13761. Epub 2024 Apr 4.